MSA capital is a venture capital firm founded in 2014. The firm manages over USD 1 billion and has invested in Chinese gene sequencing, mobility, SaaS, consumer internet and AI companies. Notable portfolio companies include Meituan, Didi, Mobike, NIO, Beijing Genomic Institute, Zhaogang, Tuija, and Mogujie. MSA’s LP base composed of regional and global institutional investors, as well as leading entrepreneurs in China.
Venture Capital
3 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.